From the clinicaltrials dot gov page, it looks like Moderna's phase 2/3 INT to cutaneous squamous cell carcinoma is now fully enrolled.

From the clinicaltrials dot gov page, it seems that Moderna's phase 2/3 INT against cutaneous squamous cell carcinoma is now fully enrolled. The status has changed from "recruiting" to "active, not recruiting". Moderna hasn't PR-ed this.

ADDITIONAL NOTE: u/Past-Track-9976 commented below: "You want to look at the enrollment. It will switch from estimated to actual when enrollment is complete." It is still estimated at this moment but again the status had changed from "recruiting" to "active, not recruiting".

Source: "A Study of (Neo)Adjuvant V940 and Pembrolizumab in Cutaneous Squamous Cell Carcinoma (V940-007)."